Drug & Supplement Interactions

Cannabidivarin (CBDV) + Triptorelin

Brand name of Triptorelin

  • Triptodur

Medically reviewed by

Also reviewed by the HelloPharmacist Editorial Team

Updated October 2026Details about this page

AI is used only to summarize verified clinical information, never the open internet. Our AI policy

The Bottom Line No Known Interaction

We found no known interaction between Cannabidivarin (CBDV) and Triptorelin in our sources.

This also applies to Triptodur, a brand name of triptorelin.

See the Full Interaction Report

Ask a Question About This Combination

Ask in your own words about taking Cannabidivarin (CBDV) with Triptorelin. The answer comes from this page’s own records.

Try:

AI answers from this page’s interaction records and our own drug and supplement information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist. How we use AI

Interaction Report

Cannabidivarin (CBDV) and Triptorelin Interaction Check

No Known Interaction Found

We did not find a documented interaction between Triptorelin and Cannabidivarin (CBDV) in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

How We Checked

Why No Interaction Is Listed for Triptorelin

Neither one has a record. Our interaction database holds no record for Cannabidivarin (CBDV) with any drug, and none for Triptorelin with any supplement, so this rests on missing data, not on a study that found nothing.

Still wondering about combining Cannabidivarin (CBDV) and Triptorelin? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
Know someone taking this combination? Share
What to Watch For

What Cannabidivarin (CBDV) Itself Has Been Linked To

  • This is not an interaction: nothing below involves Triptorelin.
  • It is the side-effect record for Cannabidivarin (CBDV) on its own, from the licensed Natural Medicines monograph.
  • If something new turns up after you add Cannabidivarin (CBDV), this list is the first place to look.
  • 2 entries are worth acting on rather than waiting out, marked below.
  • Unsteadiness / Confusion Worth Acting On Additional detail

    Orally, cannabidivarin has been associated with dizziness, somnolence, and headache. Ataxia, confusion, and dysarthria have been reported in one patient in a clinical trial who had been taking cannabidivarin 800 mg twice daily for 30 days. This patient also experienced other symptoms of intoxication, including arterial hypotension, nystagmus, diplopia, and elevated liver transaminases.

    Source: , the clinical database we license.

    2 references cited
    1. 107343. Brodie MJ, Czapinski P, Pazdera L, et al. A Phase 2 Randomized Controlled Trial of the Efficacy and Safety of Cannabidivarin as Add-on Therapy in Participants with Inadequately Controlled Focal Seizures. Cannabis Cannabinoid Res 2021;6(6):528-536. PubMed
    2. 110246. Hurley EN, Ellaway CJ, Johnson AM, et al. Efficacy and safety of cannabidivarin treatment of epilepsy in girls with Rett syndrome: A phase 1 clinical trial. Epilepsia 2022;63(7):1736-1747. PubMed

    Orally, diplopia and nystagmus have been reported in one patient in a clinical trial who had been taking cannabidivarin 800 mg twice daily for 30 days. This patient also experienced other symptoms of intoxication, including severe ataxia, arterial hypotension, dysarthria, mild confusion, and elevated liver transaminases.

    Source: , the clinical database we license.

    1 reference cited
    1. 107343. Brodie MJ, Czapinski P, Pazdera L, et al. A Phase 2 Randomized Controlled Trial of the Efficacy and Safety of Cannabidivarin as Add-on Therapy in Participants with Inadequately Controlled Focal Seizures. Cannabis Cannabinoid Res 2021;6(6):528-536. PubMed
  • Kidney problems Worth Acting On Additional detail

    Orally, azotemia and acute kidney failure have been reported in one patient in a clinical trial who had been taking cannabidivarin 800 mg twice daily for 32 days. Kidney failure resolved after treatment discontinuation.

    Source: , the clinical database we license.

    1 reference cited
    1. 107343. Brodie MJ, Czapinski P, Pazdera L, et al. A Phase 2 Randomized Controlled Trial of the Efficacy and Safety of Cannabidivarin as Add-on Therapy in Participants with Inadequately Controlled Focal Seizures. Cannabis Cannabinoid Res 2021;6(6):528-536. PubMed
  • Tremor or shakiness Additional detail

    Recorded for Cannabidivarin (CBDV) in the same Natural Medicines adverse-effect record shown under Unsteadiness / Confusion above.

  • Drowsiness / Dizziness Additional detail

    Recorded for Cannabidivarin (CBDV) in the same Natural Medicines adverse-effect record shown under Kidney problems above.

  • Low blood pressure Additional detail

    Recorded for Cannabidivarin (CBDV) in the same Natural Medicines adverse-effect record shown under Unsteadiness / Confusion above.

  • Stomach pain / Diarrhea Additional detail

    Orally, cannabidivarin has been associated with diarrhea, nausea, and abdominal pain. Drooling has been reported in one child with Rett syndrome.

    Source: , the clinical database we license.

    2 references cited
    1. 107343. Brodie MJ, Czapinski P, Pazdera L, et al. A Phase 2 Randomized Controlled Trial of the Efficacy and Safety of Cannabidivarin as Add-on Therapy in Participants with Inadequately Controlled Focal Seizures. Cannabis Cannabinoid Res 2021;6(6):528-536. PubMed
    2. 110246. Hurley EN, Ellaway CJ, Johnson AM, et al. Efficacy and safety of cannabidivarin treatment of epilepsy in girls with Rett syndrome: A phase 1 clinical trial. Epilepsia 2022;63(7):1736-1747. PubMed
  • A skin rash Additional detail

    Orally, cannabidivarin 800 mg twice daily has been associated with maculopapular rash. The rash resolved with discontinuation of cannabidivarin.

    Source: , the clinical database we license.

    1 reference cited
    1. 107343. Brodie MJ, Czapinski P, Pazdera L, et al. A Phase 2 Randomized Controlled Trial of the Efficacy and Safety of Cannabidivarin as Add-on Therapy in Participants with Inadequately Controlled Focal Seizures. Cannabis Cannabinoid Res 2021;6(6):528-536. PubMed

Showing the 10 most notable of 12 recorded effects — ranked by how unusual each one is across medicines generally, with serious effects weighted up.

Everything above comes from the Natural Medicines adverse-effect record for Cannabidivarin (CBDV) — expand a row for the licensed statement it rests on. We haven’t matched Triptorelin to its FDA label in our system yet, so we can’t compare its own side-effect list here — the leaflet that comes with your prescription is the authoritative list for Triptorelin.

If You Decide to Take Both
  • Add one new thing at a time, and note the date you started it.
  • A start date turns “I’ve been feeling off” into something a pharmacist can work with.
  • Do not stop a prescribed medicine on your own.
  • Check with your pharmacist or doctor before changing any medicine or supplement, especially if you take several or have an ongoing health condition.
Alternatives for the Same Use

Other Supplements for the Same Uses as Cannabidivarin (CBDV), and How They Mix With Triptorelin

Choosing a supplement while you take Triptorelin? Pick what you use Cannabidivarin (CBDV) for to see other options studied for it, and whether each has a documented interaction with Triptorelin.

What do you take Cannabidivarin (CBDV) for?

For Ulcerative Colitis

None of them has a documented interaction with Triptorelin.

6 other supplements have at least some evidence of a benefit for ulcerative colitis. Cannabidivarin (CBDV) itself is graded for it.

For Neuropathic Pain

None of them has a documented interaction with Triptorelin.

4 other supplements have at least some evidence of a benefit for neuropathic pain. Cannabidivarin (CBDV) itself is graded for it.

For Multiple Sclerosis (MS)

None of them has a documented interaction with Triptorelin.

3 other supplements have at least some evidence of a benefit for multiple sclerosis (MS). Cannabidivarin (CBDV) itself is graded for it.

  • Cannabis Graded No Known Interaction
  • Coenzyme Q10 Graded No Known Interaction
  • Panax Ginseng Graded No Known Interaction

For Duchenne Muscular Dystrophy

None of them has a documented interaction with Triptorelin.

2 other supplements have at least some evidence of a benefit for duchenne muscular dystrophy. Cannabidivarin (CBDV) itself is graded for it.

  • Coenzyme Q10 Graded No Known Interaction
  • Idebenone Graded No Known Interaction

For Nausea and Vomiting

None of them has a documented interaction with Triptorelin.

2 other supplements have at least some evidence of a benefit for nausea and vomiting. Cannabidivarin (CBDV) itself is graded for it.

  • Capsicum Graded No Known Interaction
  • Fish Oil Graded No Known Interaction

The grades come from the Natural Medicines database and describe the research so far, not a recommendation, and none of these supplements replaces a prescribed medicine.

Supplement

About Cannabidivarin (CBDV)

Cannabidivarin (CBDV) is a non-intoxicating compound found in cannabis that is being studied mainly for epilepsy and certain neurodevelopmental conditions. The research is still early, mostly from laboratory and animal studies plus small human trials, so it is not an approved or proven treatment. Talk to your pharmacist or doctor before trying any CBDV product.

Full Cannabidivarin (CBDV) guide: uses, dosage, safety and every interaction
Safety at a Glance

How Cannabidivarin (CBDV) Is Rated

  • Cannabidivarin (CB... Overall

    Not established

    Human safety data are very limited, so long-term effects are not well understood.

  • Pregnancy

    Avoid

    There is not enough safety information, so it is best avoided during pregnancy.

  • Breastfeeding

    Avoid

    Safety while breastfeeding is unknown, so avoid use.

More to Explore

More Pairs and Interactions to Check

Keep Checking

Other Drugs & Cannabidivarin (CBDV)

Browse every other medication we’ve checked against Cannabidivarin (CBDV) — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
0Moderate
0Minor
2,829No known interaction
No Interaction 2,829 drugs checked — show the list
How Much People Look This Up

Where Cannabidivarin (CBDV) and Triptorelin Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Cannabidivarin (CBDV)
Steady interest

#1,203 of 1,458 supplements looked up here in the last 7 days

29 days ago today
Medication Triptorelin
Top 25%

#371 of 2,830 medications looked up here in the last 7 days

29 days ago today

A rank of lookups on this site, not of how often either one is used. It counts every visit, automated ones included, and identifies no one.

Questions and Sources

Common Questions and Where This Comes From

Pharmacist Counseling Corner

Taking Cannabidivarin (CBDV) and Triptorelin Together: Common Questions

Can you take Cannabidivarin (CBDV) with Triptorelin?
We do not list a known interaction between Cannabidivarin (CBDV) and Triptorelin. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Can you take Cannabidivarin (CBDV) with Triptodur?
Triptodur is a brand name of triptorelin, so the answer is the same as for triptorelin. We do not list a known interaction between Cannabidivarin (CBDV) and Triptorelin. Everything on this page applies to Triptodur too.
Do other supplements studied for ulcerative colitis interact with Triptorelin?
None of the 6 other supplements the Natural Medicines database grades as having some evidence of a benefit for ulcerative colitis has a documented interaction with Triptorelin. A grade is the research so far, not a recommendation, and no known interaction is not proof of safety; ask your pharmacist before adding one.

Written and reviewed by the HelloPharmacist Editorial Team. Our editorial policy

Evidence & Sources

References Cited on This Page

The 2 references the cards above cite, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

Show the 2 references
  1. 107343. Brodie MJ, Czapinski P, Pazdera L, et al. A Phase 2 Randomized Controlled Trial of the Efficacy and Safety of Cannabidivarin as Add-on Therapy in Participants with Inadequately Controlled Focal Seizures. Cannabis Cannabinoid Res 2021;6(6):528-536. PubMed
  2. 110246. Hurley EN, Ellaway CJ, Johnson AM, et al. Efficacy and safety of cannabidivarin treatment of epilepsy in girls with Rett syndrome: A phase 1 clinical trial. Epilepsia 2022;63(7):1736-1747. PubMed

All 4 references behind our Cannabidivarin (CBDV) records are listed in the Cannabidivarin (CBDV) guide.

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is reviewed by the HelloPharmacist Editorial Team. See our data sources and editorial standards.

Where Does Our Data Come From?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 105,612 references behind our interaction content, 67,053 of them resolved to verified PubMed/DOI sources. See the references behind this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified November 15, 2026. The Cannabidivarin (CBDV) and Triptorelin records this page draws on were last updated October 13, 2026.
Data structure & sourcing designed and verified by .
Rating Key

What Our Interaction Ratings Mean

No interaction is on record for this pair. The other supplements and medicines on this page carry a severity rating: how serious an interaction between them is.

See what each severity means

Severity: How Serious Is It?

How clinically significant the interaction is: how much it could affect your health or your treatment.

  • MajorClinically significant. Best to avoid the combination, or use only under close professional supervision.
  • ModerateBe cautious. The combination may call for monitoring, timing changes, or a dose adjustment.
  • MinorLimited clinical concern, but still worth being aware of and mentioning to your pharmacist.
  • No Known InteractionNo documented interaction in our sources.

Still Have a Question About Cannabidivarin (CBDV) and Triptorelin?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.